Our Mission
To be a leader as a successful independent pharmaceutical company through:
- Research & Development,
- Quality,
- Manufacturing,
- Sales, and
- Customer Service.
ES Pharma is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. We are an emerging specialty pharmaceutical company with a focus on research, process chemistry, active pharmaceutical ingredient procurement, formulation development and regulatory filings. ES Pharma is committed to achieving its mission and vision of becoming an innovative pharmaceutical company.
Recent FDA News
FDA approves generic versions of blood thinner Plavix
May 17, 2012
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
FDA expands use for FilmArray Respiratory Panel
May 15, 2012
The U.S. Food and Drug Administration today expanded the use for the FilmArray Respiratory Panel, the first test that can simultaneously detect both viral and bacterial causes of respiratory infection from a single sample.
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
May 10, 2012
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called "liberation therapy" or the "liberation procedure" to treat chronic cerebrospinal venous insufficiency (CCSVI).
FDA proposal aims to help reduce unnecessary radiation exposure for children
May 9, 2012
Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging devices. In the draft guidance, FDA is recommending that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients.
FDA issues final rule on sterility testing of biological products
May 3, 2012
The U.S. Food and Drug Administration issued its final rule on sterility testing, amending the requirements for most licensed biological products.